Clinical Trial

Longterm-Evaluation of Vitelene® Against Standard

Study acronym: VITAS
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this randomised prospective multicenter longterm study is to evaluate the survival rate of the implant, wear and periprosthetic osteolysis of highly cross-linked polyethylene with and without addition of Vitamin E (UHMWPE-XE vs. UHMWPE-X) in Total Hip Arthroplasty.
Protocol Amendment History 17 amendments
This ClinicalTrials.gov record has been amended 17 times since 2012-10-22; most recent amendment 2025-11-14.
Status change: Recruiting → Active, Not Recruiting 2016-02-05
Trial Details
NCT Number NCT01713062
Lead Sponsor Aesculap AG
Conditions Osteoarthritis, Hip, Arthritis
Enrollment 400 participants
Start Date 2012-01
Primary Completion 2027-04 (estimated)
Study Completion 2030-06 (estimated)
Updated on ClinicalTrials.gov 2025-11-17